Monday, September 14, 2026

SK On Expects More U.S. ESS Orders as Tougher China Restrictions Create New Opportunities

SK On’s 9 GWh U.S. ESS contract could pave the way for additional orders as rising demand and tougher restrictions on China-linked equipment reshape the American market.

Kim Jong Un Showcases North Korea’s Most Powerful Nuclear Missile Yet—The Hwasong-20

North Korea showcased its Hwasong-20 ICBM as a key nuclear asset during a military parade marking the Workers' Party's 80th anniversary.

U.S.-South Korea Talks Heat Up Over Military Funds

The Fourth Round of Consultations on the 12th U.S.-ROK Special Measures Agreement(SMA) will be held in Seoul from the 25th to the 27th.

Tag: Neurophet

Neurophet AQUA AD Plus: The Innovative AI Tool Designated for Public Health in 2026

Neurophet's Alzheimer's treatment solution, Neurophet AQUA AD Plus, gains innovative product status, enhancing public procurement access.

Neurophet to showcase Alzheimer’s imaging platform at AAIC 2026

Neurophet will showcase its AI-driven brain imaging solutions at AAIC 2026, aiming to partner with global pharmaceutical firms for Alzheimer's treatment.

Neurophet Unveils AI-Powered Alzheimer’s Treatment Software at ITEM 2026 in Japan

Neurophet showcases AI-driven brain disease tech at ITEM 2026 in Japan, partnering with Hokuyaku Takeyama to expand market reach.

Neurophet Partners with ALZ-NET: Revolutionizing Alzheimer’s Diagnosis with AI Technology

Neurophet partners with ALZ-NET to enhance Alzheimer's care through advanced AI solutions and imaging monitoring for better patient outcomes.

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

How Neurophet AQUA is Transforming Dementia Diagnosis in South Korea: Key MOU Insights

Neurophet partners with Eisai Korea to enhance dementia screening and diagnostics using AI-based software, Neurophet AQUA.

Top News

- Our Sponsors Ad -

Follow us